Genetics · MU Sofia

19. Diseases in amino acid metabolism defects: aminoacidopathies; organic acidopathies; urea cycle defects.

Covers inborn errors of amino acid catabolism split into three groups: aminoacidopathies, organic acidopathies and urea cycle defects. Phenylketonuria, maple syrup urine disease and homocystinuria are each set out by enzyme defect, pathogenesis, clinical features, diagnosis and management. Methylmalonic and propionic acidemia follow in the same format, then the urea cycle enzymes with the OTC and CPS1 deficiencies compared, and a closing summary of clinical relevance.

Inside: 6 sections · 6 labelled pictures · 15 flashcards · 4 min

Topic 19 of 65 in the MU Sofia syllabus for Genetics (Medicine, Year 3). The free AceMed note covers it in 6 sections, about 587 words (4 min of reading), with 15 flashcards.

In this note

  1. Diseases in amino acid metabolism defects: aminoacidopathies; organic acidopathies; urea cycle defects.
  2. I. Introduction
  3. II. Aminoacidopathies
  4. III. Organic Acidopathies
  5. IV. Urea Cycle Defects (UCDs)
  6. V. Clinical Relevance

I. Introduction

Inborn errors of metabolism affecting amino acid catabolism are rare genetic disorders caused by mutations in enzymes responsible for amino acid degradation.

  • Accumulation of toxic metabolites (amino acids, organic acids, ammonia).
  • Deficiency of downstream products (e.g., neurotransmitters, energy molecules).
  • Most are inherited in an autosomal recessive manner.
  • Onset: often in infancy or early childhood, with neurological, developmental, or metabolic crises.

They can be grouped into:

  1. 1. Aminoacidopathies – defects in direct amino acid metabolism.
  2. 2. Organic acidopathies – defects in pathways producing intermediate organic acids.
  3. 3. Urea cycle defects – defects in detoxification of ammonia.

II. Aminoacidopathies

Disorders where the amino acid itself accumulates in blood/urine.

1. Phenylketonuria (PKU)

  • Defect: deficiency of phenylalanine hydroxylase (PAH) or tetrahydrobiopterin (BH₄) cofactor.
  • Pathogenesis: phenylalanine accumulates → converted into phenylketones → neurotoxicity.
  • Clinical features:
  • Intellectual disability if untreated.
  • Seizures, microcephaly.
  • Hypopigmentation (↓ tyrosine → ↓ melanin).
  • Musty/mousy odor of urine.
  • Diagnosis: newborn screening (Guthrie test, tandem MS).
  • Management: low-phenylalanine diet, tyrosine supplementation; BH₄ therapy in responsive cases.

2. Maple Syrup Urine Disease (MSUD)

  • Defect: branched-chain α-ketoacid dehydrogenase complex.
  • Pathogenesis: accumulation of leucine, isoleucine, valine → ketoacidosis, neurotoxicity.
  • Clinical features:
  • Poor feeding, vomiting.
  • Neurological signs (lethargy, seizures, developmental delay).
  • Sweet “maple syrup” odor of urine.
  • Diagnosis: elevated branched-chain AAs in plasma, organic acids in urine.
  • Management: dietary restriction of branched-chain AAs, thiamine supplementation (cofactor).

3. Homocystinuria

  • Defect: cystathionine β-synthase (CBS) deficiency (most common).
  • Pathogenesis: ↑ homocysteine → endothelial damage, connective tissue defects.
  • Clinical features:
  • Marfanoid habitus (tall, lens dislocation).
  • Intellectual disability.
  • Thrombosis (major cause of mortality).
  • Diagnosis: ↑ plasma homocysteine, ↑ methionine.
  • Management: vitamin B₆ (pyridoxine) responsive in some; also folate and B₁₂ supplementation; betaine therapy.

Continue reading free

The whole note, all 6 sections, is free with an AceMed account, with its 15 flashcards. Premium adds flashcard recall, highlights and Ask AI.

Start freeAlready a member? Open the note